Wytwarzanie produktów leczniczych jest dla nas nie tylko kwestia wykonania pewnego procesu technologicznego, ale misją związaną z człowiekiem opartą na wysokim standardzie jakości, bezpieczeństwa i skuteczności leków.
Mamy aktywną i kluczową rolę w podnoszeniu standardów życia codziennego. Sprawiamy, że społeczeństwo jest lepiej poinformowane, zdrowsze, szczęśliwsze i bezpieczniejsze
Zbiorowy projekt „Szczycę się pracą swoich rodziców” został wyróżniony w konkursie tradycyjnych rocznych nagród w zakresie zasobów ludzkich. Ceremonia wręczenia nagród odbyła się 20 01.2016 w Rainbow Plaza w Sofii.
Projekt Bułgarskiej sieci Umowy Globalnej ONZ został wyróżniony jako najlepszy projekt zintegrowania edukacji z biznesem za rok 2015. Nagrodę przyznaje się projektowi w zakresie zasobów ludzkich za osiągnięcie efektywnego oraz skutecznego współdziałania biznesu z edukacją.
On the 10th of December (Wednesday) from 15:00 o’clock, in the building of the former Central Sofia Bath (next to TZUM) starts a unique Children’s Career Fair. Within the fair, over 16 companies will show some of their professions in an interesting and fun way for children. Entrance is free, and the recommended age for the children is from 9 to 16 years.
On December 10th the first children career fair in the country took place.It marked the successful final of "I am Proud of the Work of My Parents" 2014, a project of the Bulgarian Network of UN Global Contract. At the stand of Sopharma, the guests could see how "elephant tooth paste" was made and could win a present in return for a hug by the "Healthy" machine. All companies participating in the project presented the main professions related to their business, various workshops, presentations and entertainments.
Thirty two participants took place in the qualifications for the basic scheme of the 41st edition of "Dr.Todor Todorov" Tennis Tournament for Men organized by the Bulgarian Tennis Federation. Sofia Tennis Hall at Boris Garden Park became again the scene of serious battles and emotions for the prestigious trophy. "Dr.Todor Todorov" tournament is the oldest professional tennis tournament for men in our country.
Cytisine is finally emerging from behind the Iron Curtain as a viable treatment to help people quit smoking. Smoking accounts for more avoidable public health damage than anything else, including obesity. The path to giving up the vice is paved with smoking cessation aids, such as nicotine gums and patches and the drug varenicline (Chantix). But there’s another treatment that works at least as well. Though it’s been in use since the 1960s, many American doctors have never heard of it. It costs a fraction of what Pfizer’s Chantix does, and it’s even cheaper than patches and gums.
Nancy A. Rigotti, MD, of the Tobacco Research and Treatment Center at Massachusetts General Hospital and Harvard in Boston, agreed in aneditorial accompanying the NEJM paper. However, getting the drug to the U.S. market could be a challenge, Rigotti told MedPage Today. The manufacturer in Bulgaria never saw a market for the drug in the U.S. and so never tried for approval, she explained. "We're sort of stuck here," she said in an interview.
With the start of the financial year the management of Sopharma AD parts with the company’s Commercial Director. Vladimir Stoychev joined the team of Sopharma AD in September 2001 as a warehouse manager for export goods. Later he was transferred to the position of Head of Kazahstan office. His good work lead eventually to his promotion to Commercial Director of Sopharma AD in 2007. The management team of the company wishes Mr. Stoychev success in his new professional endavoures. The Executive Director of the company will temporarily be responsible for the export markets.
We would like to notify, that Sopharma AD received the following opinion from Momina krepost AD:
On 27 March 2013, we received a notification pursuant to art. 151, par. 3 of POSA, accompanied by a tender offer under art. 149, par. 6 of POSA from Sopharma AD for purchasing of the shares of the remaining shareholders of Momina Krepost AD.
In accordance with art. 151, par. 5 of POSA and within the statutory period we present a motivated opinion regarding the tender offer.